James W. Fitzsimmons

Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN.

Part of Boston Scientific Corp., EndoVascular Technologies, Inc. is a company that makes invasive endovascular systems. The company is based in Menlo Park, CA. The company was founded by Wesley D. Sterman. EndoVascular Technologies was acquired by Guidant Corp. on December 22, 1997 for $145.32 million.

VNUS Medical Technologies, Inc. provides medical devices and procedures for the minimally invasive treatment of venous reflux disease, an underlying cause of varicose veins. Venous reflux disease results in symptoms such as leg pain, swelling, fatigue, skin ulcers, and painful varicose veins. The company was founded on January 31, 1995 and is headquartered in San Jose, CA.

Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA.

Asthmatx, Inc. develops catheter-based outpatient procedure that provides asthma control for adult severe asthma patients. The company was founded in 2003 and is headquartered in Sunnyvale, CA.

Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients.

EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA.

Archus Orthopedics, Inc. develops implantable medical devices for spine disorders resulting from degenerative changes in the facet joints. Its products include Total Facet Arthroplasty System and Archus-UWABL spine simulator. Archus Orthopedics was founded by Scott J. Wolf in July 2001 and is headquartered in Redmond, WA.